Stay updated!

Smart, accurate, fast, adaptable and strong – learn more about how INIFY® Prostate Screening empowers the pathologist. User and developer interviews, short demos and answers to frequently asked questions on both digital pathology and INIFY are examples of upcoming content.

Newsletter sign up

Sign up to get the latest on product updates, events and company news

Sign up

GDPR

ContextVision has developed and implemented a Policy to ensure compliance to the General Data Protection Regulations, GDPR. This is based on a respect for the personal integrity of our customers and partners and it serves as a guideline to our employees for how to handle data governed by the new regulations.

ContextVision is a medical technology software company specialized in image analysis and artificial intelligence. As the global market leader within image enhancement, we are a trusted partner to leading manufacturers of ultrasound, X-ray and MRI equipment around the world.

Our expertise is to develop powerful software products, based on proprietary technology and artificial intelligence for image-based applications. Our cutting-edge technology helps clinicians accurately interpret medical images, a crucial foundation for better diagnosis and treatment.

With INIFY^® Prostate Screening we are now entering the fast-growing digital pathology market. We are re-investing significantly in our product portfolio of decision support tools and we are dedicated to becoming a leading resource for pathologists to radically develop cancer diagnosis and improve patient care.

The company, established in 1983, is based in Sweden with local representation in the U.S., Japan, China and Korea. ContextVision is listed on the Oslo Stock Exchange under the ticker CONTX.